The National Institute of Neurological Disorders and Stroke (NINDS) is offering the NeuroNEXT Small Business Innovation Grant to fund exploratory clinical trials of investigational agents for diseases aligned with NINDS’ strategic plan. This grant aims to support small businesses in providing the data necessary for designing future clinical studies in the field of neurological disorders. Applications should focus on drugs, biologics, surgical therapies, or devices. The closing date for applications is April 5, 2021.
Opportunity ID: 300497
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-628 |
| Funding Opportunity Title: | NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Feb 05, 2018 |
| Last Updated Date: | Aug 11, 2020 |
| Original Closing Date for Applications: | Jan 05, 2021 |
| Current Closing Date for Applications: | Apr 05, 2021 |
| Archive Date: | May 05, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding opportunity for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
This Funding Opportunity Announcement (FOA) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS’ strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-628.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Updated close date as per NOT-NS-20-090 | Aug 11, 2020 | |
| Feb 05, 2018 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-628 |
| Funding Opportunity Title: | NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Feb 05, 2018 |
| Last Updated Date: | Aug 11, 2020 |
| Original Closing Date for Applications: | Jan 05, 2021 |
| Current Closing Date for Applications: | Apr 05, 2021 |
| Archive Date: | May 05, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding opportunity for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
This Funding Opportunity Announcement (FOA) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS’ strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-628.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-18-628 |
| Funding Opportunity Title: | NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.853 — Extramural Research Programs in the Neurosciences and Neurological Disorders |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 05, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 05, 2021 |
| Archive Date: | Feb 10, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding opportunity for eligibility details |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) encourages small business applications for exploratory clinical trials of investigational agents (drugs, biologics, surgical therapies or devices) that may contribute to the justification for and provide the data required for designing clinical studies. Diseases chosen for study should be based on the NINDS’ strategic plan and clinical research interests (www.ninds.nih.gov/funding/areas/index.htm). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-18-628.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00238064 | Mar 05, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00260220 | Mar 05, 2018 | Apr 05, 2021 | View |
Package 1
Mandatory forms
300497 RR_SF424_2_0-2.0.pdf
300497 PHS398_CoverPageSupplement_4_0-4.0.pdf
300497 RR_OtherProjectInfo_1_4-1.4.pdf
300497 PerformanceSite_2_0-2.0.pdf
300497 RR_KeyPersonExpanded_2_0-2.0.pdf
300497 RR_Budget_1_4-1.4.pdf
300497 PHS398_ResearchPlan_4_0-4.0.pdf
300497 SBIR_STTR_Information_1_2-1.2.pdf
Optional forms
300497 RR_SubawardBudget30_1_4-1.4.pdf
300497 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
300497 RR_SF424_2_0-2.0.pdf
300497 PHS398_CoverPageSupplement_5_0-5.0.pdf
300497 RR_OtherProjectInfo_1_4-1.4.pdf
300497 PerformanceSite_2_0-2.0.pdf
300497 RR_KeyPersonExpanded_2_0-2.0.pdf
300497 RR_Budget_1_4-1.4.pdf
300497 PHS398_ResearchPlan_4_0-4.0.pdf
300497 SBIR_STTR_Information_1_3-1.3.pdf
300497 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
300497 RR_SubawardBudget30_1_4-1.4.pdf
300497 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
